"These findings indicate that frailty is a strong independent predictor for adverse in-patient outcomes in hospitalized CML patients . . . Frailty not only poses greater risk for in-hospital death in ...

Genetic testing for chronic myeloid leukemia (CML) can tell doctors if someone has leukemia, what type they may have, and whether treatment is working. The tests look for atypical changes in certain ...